Real-life experience in two cases of secondary prophylaxis with letermovir for CMV infection in solid organ transplantation

Real-life experience in two cases of secondary prophylaxis with letermovir for CMV infection in solid organ transplantation

ABSTRACT The use of valganciclovir as secondary prophylaxis for cytomegalovirus (CMV) infection in solid organ transplantation (SOT) is the most prevalent therapeutic choice, but it has been dismissed by the presence of resistance and toxicity. Letermovir (LMV) is indicated as primary prophylaxis in...

Full description

Bibliographic Details
Main Authors: Ana-Belén Pérez, Marta Santos Bravo, Elisa Vidal-Verdú, Aurora Páez-Vega, José-Manuel Vaquero-Barrios, José-Luis Montero, María-Ángeles Marcos, Julián Torre-Cisneros
Format: Article
Language:English
Published: American Society for Microbiology 2023-12-01
Series:Microbiology Spectrum
Subjects:
cytomegalovirus
letermovir
secondary prophylaxis
transplant recipients
antiviral
resistance mutation
Online Access:https://journals.asm.org/doi/10.1128/spectrum.01630-23

Internet

https://journals.asm.org/doi/10.1128/spectrum.01630-23

Similar Items